Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging.

OBJECTIVE The objective of our study was to determine the accuracy of endorectal MRI and MR spectroscopic imaging (MRSI) in the diagnosis of prostate cancer in patients with an elevated serum prostate-specific antigen (PSA) level. MATERIALS AND METHODS We retrospectively identified 40 patients with an elevated serum PSA level and without a histologic diagnosis of prostate cancer who underwent endorectal MRI and MRSI at our institution. On the basis of MRI findings alone and then combined MRI and MRSI findings, a single experienced observer rated the presence or absence of prostate cancer in each side of the prostate on a 5-point scale (1 = definitely absent, 5 = definitely present). Areas under the receiver operating characteristic (ROC) curve were calculated using the hemiprostate as the unit of analysis. The presence or absence of cancer on subsequent endorectal sonographically guided sextant biopsy was used as the standard of reference. RESULTS Biopsy revealed no cancer in 24 patients, bilateral cancer in 11, and unilateral cancer in five. The areas under the ROC curve for the diagnosis of prostate cancer by hemigland was 0.70 for MRI alone and 0.63 for combined MRI and MRSI (no significant difference, p = 0.32). CONCLUSION Endorectal MRI and MRSI are reasonably accurate for the diagnosis of prostate cancer in patients with an elevated serum PSA level, but the remaining limitations suggest that MRI and MRSI should be used as a supplement rather than a replacement for biopsy using the current technology and diagnostic criteria.

[1]  H. Hricak,et al.  Prostate cancer imaging , 2008, Acta radiologica.

[2]  K. Badani,et al.  Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.

[3]  C C Schulman,et al.  Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? , 2001, The Journal of urology.

[4]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[5]  M. Zerbib,et al.  Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. , 2005, European urology.

[6]  P. Carroll,et al.  Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.

[7]  A. Gelabert-Más,et al.  The value of endorectal MRI in the early diagnosis of prostate cancer. , 2003, European urology.

[8]  J. Hugosson,et al.  Transrectal ultrasound examination of the prostate: complications and acceptance by patients. , 1993, British journal of urology.

[9]  J. Speight,et al.  The Use of Imaging Modalities in the Evaluation and Treatment of Prostate Cancer , 2008 .

[10]  W S Ng,et al.  Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.

[11]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.

[12]  D. Bostwick,et al.  Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.

[13]  John Kurhanewicz,et al.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. , 2008, Journal of endourology.

[14]  A. Partin,et al.  Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells. , 1999, The Journal of urology.

[15]  J. Hugosson,et al.  Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. , 2003, European urology.

[16]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[17]  J. Pauly,et al.  Improved solvent suppression and increased spatial excitation bandwidths for three‐dimensional press CSI using phase‐compensating spectral/spatial spin‐echo pulses , 1997, Journal of magnetic resonance imaging : JMRI.

[18]  C. Öbek,et al.  Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. , 1999, The Journal of urology.

[19]  Bernd Hamm,et al.  Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.

[20]  Silvia D. Chang,et al.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.

[21]  P. Carroll,et al.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.

[22]  P. Scardino,et al.  Pathologic basis of the sonographic appearance of the normal and malignant prostate. , 1989, The Urologic clinics of North America.

[23]  Vikas Kundra,et al.  Imaging in oncology from the University of Texas M. D. Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. , 2007, AJR. American journal of roentgenology.

[24]  R Alagappan,et al.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.

[25]  Erica Markiewicz,et al.  High spectral and spatial resolution MRI of age‐related changes in murine prostate , 2008, Magnetic resonance in medicine.

[26]  M. Terris,et al.  Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. , 1998, The Journal of urology.

[27]  K. Shinohara,et al.  Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. , 1996, The Journal of urology.

[28]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[29]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[30]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[31]  J. Kurhanewicz,et al.  Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.

[32]  J. Weinreb,et al.  MR imaging of the prostate: 1.5T versus 3T. , 2007, Magnetic resonance imaging clinics of North America.

[33]  J. Kurhanewicz,et al.  Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.

[34]  G N Collins,et al.  Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance. , 1993, British journal of urology.

[35]  J. Pauly,et al.  Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.

[36]  N. Faccioli,et al.  Imaging findings of genitourinary tumors in the elderly. , 2008, Radiologic clinics of North America.

[37]  Jean-Jacques Patard,et al.  Value of Ultrasound-Guided Systematic Sextant Biopsies in Prostate Tumor Mapping , 1999, European Urology.

[38]  Hideaki Miyake,et al.  Predictors of prostate cancer on repeat transrectal ultrasound‐guided systematic prostate biopsy , 2003, International journal of urology : official journal of the Japanese Urological Association.

[39]  A. Weaver,et al.  Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. , 2001, The Journal of urology.